Table 1.
Critical surface pressure πc values for monolayers having different lipid compositions in the presence of the SARS derived peptides as indicated
Lipid composition of the monolayers | SARSPTM |
SARSFP |
SARSIFP |
SARSFP + SARSPTM (1:1) |
SARSFP + SARSIFP (1:1) |
SARSIFP + SARSPTM (1:1) |
|||
---|---|---|---|---|---|---|---|---|---|
Expa | Exp | Exp | Exp | Aver b | Exp | Aver | Exp | Aver | |
POPC | 35 | 32 | 40 | 40 | 33.5 | 36 | 36 | 32 | 37.5 |
POPC/POPG (7:3) | 45 | 41 | 26 | 36 | 43 | 30 | 33.5 | 28 | 35.5 |
POPC/ESM/CHOL(8:1:1) | 31 | 25 | 29 | 35 | 28 | 43 | 27 | 40 | 30 |
POPC/CHOL (8:2) | 30 | 24 | 16 | 32 | 27 | 26 | 20 | 28 | 23 |
POPC/ESM (8:2) | – | – | – | 38 | – | 36 | – | 35 | - |
Exp, experimental values obtained through the analysis of the data presented in Fig. 2.
Aver, average value obtained from the sum of the individual experimental values.